Although the plant will only create around twenty new jobs, company spokesman, John Brewer, said the decision to give it the go ahead will secure many more. “This means we can now progress the investment in the bottle-making unit that will support the production of Ribena and Lucozade products,” he said.
“We are delighted GlaxoSmithKline has made this investment and excited about developing the new facility. It safeguards the future of the Coleford factory.”
Announcing the plans in November 2008, GlaxoSmithKline’s chief executive Andrew Witty said: “Lucozade and Ribena are outstanding brands with strong heritage and multiple opportunities for further development and growth. The consumer business is a core part of GSK. We are investing in it as a source of growth so that it can play its part in growing and diversifying GSK’s overall sales.”
The new bottling plant, due for completion in 2010, will be one of the largest in Europe. It will produce bottles currently brought in from North Wales.
Bosses at the firm, which boasts that it has produced the first 100% recycled plastic bottle, say the decision will reduce the company’s carbon footprint.
Source: Ribena
© FoodBev Media Ltd 2024